Workflow
安必平(688393) - 2023 Q3 - 季度财报
LBPMedicineLBPMedicine(SH:688393)2023-10-30 16:00

Important Content Reminder This section outlines the company's formal assurances regarding the accuracy and completeness of its quarterly report Assurance of Truthfulness by Board, Supervisory Board, and Senior Management The board, supervisory board, senior management, and key financial officers collectively guarantee the truthfulness and completeness of the quarterly report and its financial statements - The company's board of directors, supervisory board, and senior management assume legal responsibility for the truthfulness, accuracy, and completeness of the quarterly report content2 - The company's principal officer, officer in charge of accounting, and head of the accounting department guarantee the truthfulness, accuracy, and completeness of the financial information3 Key Financial Data This section presents the company's key financial performance indicators, balance sheet metrics, and non-recurring items, along with explanations for significant changes Key Accounting Data and Financial Indicators The company reported significant Q3 revenue and net profit growth, yet year-to-date cumulative figures declined, alongside a substantial decrease in operating cash flow and increased R&D investment Key Accounting Data and Financial Indicators | Item | Current Reporting Period (Q3 2023) | YoY Change (%) | Year-to-Date (YTD 2023) | YoY Change (%) | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 143,552,528.41 | - | 354,506,458.37 | -5.29 | | Net Profit Attributable to Shareholders of Listed Company | 19,489,757.01 | 130.95 | 37,594,415.51 | -13.86 | | Net Profit Attributable to Shareholders of Listed Company Excluding Non-Recurring Gains and Losses | 21,491,387.99 | 125.66 | 35,456,024.58 | -14.00 | | Net Cash Flow from Operating Activities | Not applicable | Not applicable | 3,210,037.42 | -80.50 | | Basic Earnings Per Share (RMB/share) | 0.21 | 133.33 | 0.40 | -14.89 | | Diluted Earnings Per Share (RMB/share) | 0.20 | 122.22 | 0.40 | -14.89 | | Weighted Average Return on Net Assets (%) | 1.56 | Increased by 0.87 percentage points | 3.02 | Decreased by 0.58 percentage points | | Total R&D Investment | 21,082,857.52 | 26.91 | 54,082,671.78 | 12.93 | | R&D Investment as % of Operating Revenue (%) | 14.69 | Increased by 2.09 percentage points | 15.26 | Increased by 2.47 percentage points | Key Balance Sheet Indicators | Indicator | End of Current Reporting Period (2023.09.30) | End of Prior Year (2022.12.31) | Change from Prior Year-End (%) | | :--- | :--- | :--- | :--- | | Total Assets | 1,381,770,194.59 | 1,392,783,829.88 | -0.79 | | Total Equity Attributable to Shareholders of Listed Company | 1,264,081,082.24 | 1,228,605,285.24 | 2.89 | Non-Recurring Gains and Losses and Amounts The current period's total non-recurring gains and losses were negative due to net non-operating expenses, while year-to-date figures were positive, driven by government subsidies and entrusted investment income Non-Recurring Gains and Losses and Amounts | Item | Amount for Current Reporting Period (Q3 2023) | Amount Year-to-Date (YTD 2023) | | :--- | :--- | :--- | | Gains/Losses from Disposal of Non-Current Assets | 1,003.88 | -70,137.79 | | Government Subsidies Included in Current Profit/Loss | 220,368.28 | 2,815,782.56 | | Gains/Losses from Entrusted Investment or Asset Management | -149,576.43 | 3,492,706.98 | | Other Non-Operating Income and Expenses | -2,453,706.86 | -3,953,625.74 | | Other Profit/Loss Items Meeting the Definition of Non-Recurring Gains/Losses | - | 161,982.08 | | Less: Income Tax Impact | -389,345.00 | 205,298.39 | | Minority Interest Impact (After Tax) | 9,064.85 | 103,018.77 | | Total | -2,001,630.98 | 2,138,390.93 | Changes in Key Accounting Data, Financial Indicators and Reasons Current period net profit and non-recurring net profit significantly increased due to higher revenue and lower expenses, while year-to-date operating cash flow declined sharply from reduced sales collections and increased employee compensation - Net profit attributable to shareholders and net profit attributable to shareholders excluding non-recurring gains and losses for the current period increased by 130.95% and 125.66% respectively, primarily due to increased revenue and reduced period expenses9 - Net cash flow from operating activities decreased by 80.50% year-to-date, mainly due to lower sales collections and increased employee compensation compared to the prior year9 - Basic earnings per share increased by 133.33% for the current period, primarily driven by increased profit9 Shareholder Information This section provides details on the total number of shareholders and the top ten shareholders' holdings, including information on controlling shareholders and related parties Total Number of Common Shareholders, Preferred Shareholders with Restored Voting Rights, and Top Ten Shareholders' Holdings As of the reporting period end, the company had 8,263 common shareholders, with high concentration among the top ten, including a significant combined stake held by controlling shareholder Cai Xiangting and his affiliates - The total number of common shareholders at the end of the reporting period was 8,26310 Top 10 Shareholders' Holdings | Shareholder Name | Shareholder Nature | Number of Shares Held (shares) | Shareholding Percentage (%) | | :--- | :--- | :--- | :--- | | Cai Xiangting | Domestic Natural Person | 19,817,000 | 21.18 | | Guangzhou Kaiduo Investment Consulting Center (Limited Partnership) | Other | 12,951,400 | 13.84 | | Zhuji Gaotejia Ruian Investment Partnership (Limited Partnership) | Other | 5,628,313 | 6.02 | | Xiamen Qianjing Enterprise Management Partnership (Limited Partnership) | Other | 5,358,418 | 5.73 | | Guangzhou Da'an Gene Technology Co., Ltd. | Domestic Non-State-Owned Legal Person | 3,486,000 | 3.73 | | Chongqing Gaotejia Ruian Equity Investment Fund Partnership (Limited Partnership) | Other | 2,407,600 | 2.57 | | Hangzhou Gaotejia Ruihai Investment Partnership (Limited Partnership) | Other | 1,480,679 | 1.58 | | Hangzhou Ruihong Investment Partnership (Limited Partnership) | Other | 722,467 | 0.77 | | Pan Weihua | Domestic Natural Person | 578,277 | 0.62 | | Feng Xiaodong | Domestic Natural Person | 513,888 | 0.55 | - Controlling shareholder Cai Xiangting is the executive partner of Guangzhou Kaiduo Investment Consulting Center (Limited Partnership), holding 69.64% of its partnership interest11 - Zhuji Gaotejia Ruian Investment Partnership, Chongqing Gaotejia Ruian Equity Investment Fund Partnership, Hangzhou Gaotejia Ruihai Investment Partnership, and Hangzhou Ruihong Investment Partnership are parties acting in concert11 Other Reminders This section addresses any other significant operational information requiring investor attention during the reporting period Other Important Information Regarding the Company's Operating Performance During the Reporting Period Requiring Investor Attention The company has no other significant operating information requiring special investor attention during the reporting period - The company has no other important operating information requiring investor attention during the reporting period12 Quarterly Financial Statements This section presents the company's unaudited consolidated financial statements, including the balance sheet, income statement, and cash flow statement Type of Audit Opinion The financial statements for the current quarter are unaudited - The financial statements for the current quarter are unaudited12 Financial Statements This section presents the company's unaudited consolidated balance sheet, income statement, and cash flow statement as of September 30, 2023, and for the nine months then ended Consolidated Balance Sheet As of September 30, 2023, total assets slightly decreased, driven by lower current assets and higher non-current assets, while total liabilities decreased and owners' equity slightly grew Consolidated Balance Sheet Key Item Changes (2023.09.30 vs 2022.12.31) | Item | September 30, 2023 (RMB) | December 31, 2022 (RMB) | Change (%) | | :--- | :--- | :--- | :--- | | Cash and Cash Equivalents | 64,396,563.04 | 90,910,709.73 | -29.17 | | Financial Assets Held for Trading | 61,204,917.06 | 175,536,506.82 | -65.17 | | Accounts Receivable | 250,622,859.34 | 236,164,593.91 | 6.12 | | Inventories | 75,920,754.68 | 63,073,696.31 | 20.37 | | Non-Current Assets Due Within One Year | 72,853,774.43 | 0 | Newly Added | | Total Current Assets | 550,482,342.58 | 595,076,395.73 | -7.50 | | Other Non-Current Financial Assets | 173,238,842.50 | 147,449,916.08 | 17.49 | | Development Expenditures | 10,941,294.39 | 1,463,347.82 | 647.75 | | Total Non-Current Assets | 831,287,852.01 | 797,707,434.15 | 4.21 | | Total Assets | 1,381,770,194.59 | 1,392,783,829.88 | -0.79 | | Total Current Liabilities | 90,505,774.12 | 114,264,335.81 | -20.79 | | Total Liabilities | 142,721,204.12 | 170,447,006.45 | -16.38 | | Total Equity Attributable to Parent Company Shareholders | 1,264,081,082.24 | 1,228,605,285.24 | 2.89 | - Cash and cash equivalents and financial assets held for trading significantly decreased, while accounts receivable and inventories increased13 - Development expenditures significantly increased, reflecting the company's increased investment in research and development14 Consolidated Income Statement For the first three quarters of 2023, total operating revenue, operating profit, and net profit all declined year-on-year, while sales and R&D expenses increased as a percentage of revenue Consolidated Income Statement Key Item Changes (Q1-Q3 2023 vs Q1-Q3 2022) | Item | Q1-Q3 2023 (Jan-Sep) (RMB) | Q1-Q3 2022 (Jan-Sep) (RMB) | YoY Change (%) | | :--- | :--- | :--- | :--- | | Total Operating Revenue | 354,506,458.37 | 374,325,569.60 | -5.29 | | Operating Cost | 109,012,703.38 | 104,857,804.61 | 3.96 | | Selling Expenses | 125,589,751.86 | 132,682,257.48 | -5.35 | | Administrative Expenses | 58,819,729.69 | 53,795,656.72 | 9.34 | | R&D Expenses | 44,604,725.21 | 47,111,809.08 | -5.32 | | Operating Profit | 24,392,685.66 | 39,189,506.75 | -37.89 | | Total Profit | 20,439,059.92 | 38,591,651.76 | -47.03 | | Net Profit | 18,830,785.55 | 34,030,155.66 | -44.66 | | Net Profit Attributable to Parent Company Shareholders | 37,594,415.51 | 43,644,589.05 | -13.86 | | Basic Earnings Per Share (RMB/share) | 0.40 | 0.47 | -14.89 | - Total operating revenue decreased by 5.29% year-on-year, leading to significant declines in operating profit, total profit, and net profit1920 - Minority interest income/loss was negative and the loss expanded, impacting net profit attributable to parent company shareholders20 Consolidated Cash Flow Statement For Q1-Q3 2023, net operating cash flow significantly decreased, while net investing cash outflow narrowed, net financing cash outflow slightly increased, and period-end cash and cash equivalents declined year-on-year Consolidated Cash Flow Statement Key Item Changes (Q1-Q3 2023 vs Q1-Q3 2022) | Item | Q1-Q3 2023 (Jan-Sep) (RMB) | Q1-Q3 2022 (Jan-Sep) (RMB) | YoY Change (%) | | :--- | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 3,210,037.42 | 16,462,893.85 | -80.50 | | Net Cash Flow from Investing Activities | -15,856,588.49 | -116,031,451.65 | 86.35 (Loss narrowed) | | Net Cash Flow from Financing Activities | -15,888,900.14 | -16,201,889.92 | 1.93 (Loss narrowed) | | Net Increase in Cash and Cash Equivalents | -28,614,146.69 | -115,580,870.56 | 75.25 (Loss narrowed) | | Cash and Cash Equivalents at Period End | 61,388,563.04 | 100,885,273.04 | -39.15 | - Decreased cash received from sales of goods and services, coupled with increased employee compensation, were the primary reasons for the significant decline in net cash flow from operating activities2324 - Net cash outflow from investing activities significantly narrowed, mainly due to a substantial reduction in cash paid for the acquisition of fixed assets, intangible assets, and other long-term assets, as well as cash paid for investments24 Adjustments to Financial Statements at the Beginning of the First Year of Application of New Accounting Standards or Interpretations from 2023 The company did not adopt new accounting standards or interpretations from 2023 that required adjustments to the financial statements at the beginning of the first year of application - The company did not adopt new accounting standards or interpretations from 2023 that required adjustments to the financial statements at the beginning of the first year of application25